Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction

American Journal of Cardiology

Volumn 79, Issue 8, 1997, Pages 1118-1120

  Bart, Bradley A ^a   Gattis, Wendy A ^b   Diem, Susan J ^b   O'Connor, Christopher M ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SODIUM;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CREATININE BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; PRIORITY JOURNAL; RASH; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UREMIA;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG UTILIZATION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030978716     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00060-X     Document Type: Article

References (11)

1. Cohn JN. The management of chronic heart failure. N Engl J Med 1996;335:490-498.
2. Philbin EF, Andreou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832-838.
3. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
4. Luther P, Baldus D, Beckham V, Wittenberg C, Rich MW. Adherence to prescribed medications in elderly patients with congestive heart failure. Geriatr Cardiol 1995;32-40.
5. Clinical Quality Improvement Network Investigators. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Arch Intern Med 1996;156:1669-1673.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
7. Young JB, Weiner DH, Yusuf S, Pratt CM, Kostis JB, Weiss MB, Schroeder E, Guillote M. Patterns of medication use in patients with heart failure: a report from the Registry of Left Ventricular Dysfunction (SOLVD). South Med J 1995;88:514-523.
8. Marquis MS, Davies AR, Ware JE Jr. Patient satisfaction and change in medical care provider: a longitudinal study. Med Care 1983;21:821-829.
9. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
10. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, for the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-677.
11. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.